We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe

MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry

MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry

Scope

Coding, payment mechanism, reimbursement tariffs, pathway to create or improve reimbursement situation

 

Project-based on-demand work or >95 off-the-shelf syndicated reports

Countries
19 EU
Availability
Mixed
Scope

Seminars on introduction into market access for medical devices and IVD tests, seminars on reimbursement systems in individual countries (>70 reports)

 

Syndicated analytical reports on the topics of HTA, innovation funding, reimbursement of health apps

Countries
19 EU
Availability
Off-the-shelf
Scope

Subscription service with email alerts about initiated or published health technology assessments of medical devices and in-vitro diagnostic tests from 56 HTA organizations globally

Countries
22 countries globally
Availability
On-demand
Scope

Subscription service with email alerts about key reimbursement developments for medical devices and in-vitro diagnostic tests (codes, DRG system, coverage decisions, innovation funding) from 29 organizations in Europe and globally

Countries
14 EU + global
Availability
On-demand

Why us?

Analyses from the same vendor for 19 different EU countries
Analyses from the same vendor for 19 different EU countries

Save money and time, get standardized analysis

Pharma approach is put aside
Pharma approach is put aside

Work with a company truly specialized in medical devices and diagnostics

Getting results instantly (reports) or within 4-8 weeks (services)
Getting results instantly (reports) or within 4-8 weeks (services)

Make business decisions quickly

15 out of top-30 companies choose MTRC for reimbursement support
15 out of top-30 companies choose MTRC for reimbursement support

Work with a provider who understands industry’s needs

More than 120 projects accomplished each year
More than 120 projects accomplished each year

Work with a provider who has experience in your field

Team of 15 specialists in 6 countries
Team of 15 specialists in 6 countries

Work with a provider with a Pan-European capacity and in-house coverage of key languages, including French, German and Italian

More than 300 internal instructions and protocols
More than 300 internal instructions and protocols

Be sure about quality of the results

To stay up-to-date, we daily monitor developments of reimbursement systems in Europe

Subscribe to our newsletter to get updates every 2nd week

Only 40% of the news is reported in the free-of-charge newsletter. Access our paid services "HTA Alerts" and "Reimbursement Alerts" to get full, customized reports from more than 90 reimbursement and HTA organizations globally

07 Aug 2020
The focus of the service is on reimbursement decisions (new procedure codes, DRG change, coverage decisions, innovation funding, clinical guidelines) in 14 European countries and globally. Only in Europe, 29 organizations are monitored. All news are classified by 31 Technology Group and alerts are sent every 2 weeks. This is a twin service for "HTA Alerts", where we track initiated or published HTAs from 56 organizations globally.

18

Sep 2020

In July 2020, the French National Authority for Health (HAS) issued an update of the methodological guide for the economic evaluation of medical technologies. The main changes aimed to improve the interpretation of the results and the uncertainty, to clarify technical points, and to integrate methodological changes that have occurred since 2011.

17

Sep 2020

On September 7, 2020, the Swiss Medical Board has announced that the organization will discontinue its operations at the end of 2021.

16

Sep 2020

In September 2020, a completed mini-method assessment for the MitraClip for percutaneous mitral valve repair was issued within the New Methods framework. The Oslo University Hospital carried out the evaluation. The method was recommended for routine use in hospitals.

15

Sep 2020

On September 03, 2020, the National Institute for Health and Care Excellence (NICE) issued medical technologies guidance on Axonics sacral neuromodulation (SNM) system for treating refractory overactive bladder. NICE recommended Axonics SNM to be adopted in the NHS and considered as an alternative when another treatment is not effective.

Our two core services are the provision of off-the-shelf and on-demand reimbursement analysis and the development of reimbursement strategy for medical devices in 19 European countries

Analysis

Reimbursement

  • Availability of procedure / reimbursement code
  • Reimbursement mechanism (diagnosis-related group or fee for service)
  • Availability of add-on reimbursement
  • Availability of innovation funding
  • Reimbursement tariffs

National funding

Willingness to pay for technology, based on:

  • Statements from national commissioners (e.g., NHS England)
  • Health Benefit Catalogues (e.g. in Spain, LEA Levels in Italy)
  • National clinical guidance (e.g. NICE in the UK, Haute Autorité de Santé in France, Socialstyrelsen in Sweden)
  • National health technology assessments in connection with reimbursement decisions (e.g. NICE for Technology Appraisal in the UK, Haute Autorité de Santé in France)
  • Specific funding frameworks (e.g., “New method” in Norway)
Strategy

Reimbursement strategy

Pathway to get reimbursement:

  • Overview of drivers and barriers for adoption
  • Overview of key reimbursement and funding pathways (including state-sponsored studies and innovation funding)
  • Detailed presentation of individual pathways (process, stakeholders, requirements, timelines)
  • Action plan

Check our specific propositions for: Med Tech industry, IVD industry, Investors

Our services cover 19 European countries, including Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Switzerland and Turkey

We provide services for major types of medical technologies

Implantable devices

Interventional procedures

Non-in­ter­ven­tional procedures

In-vitro diagnostic tests

Medical aids

Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, endoscopy and more

Confidence in results

We have established numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:

  • Standard Operating Procedures and Work Instructions
  • Access to official coding and DRG manuals, tariff lists and grouping software
  • A team comprised of experienced Clinical Coders with a medical background
  • Quick access to health authorities to address uncertainties
  • Ongoing research program to get insights from payer and provider interviews
  • All reports are reviewed by the CEO before release

Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • 3D conformal radiation therapy
  • Ablation of heart tissue for atrial fibrillation
  • Ambulatory mammography
  • Angioplasty of arteries of lower extremities for peripheral artery disease
  • Arthroscopic interventions on knee
  • Atherectomy for peripheral artery disease
  • Balloon kyphoplasty
  • Balloon sinus dilation for chronic sinusitis
  • Bariatric surgery
  • Biologic and synthetic skin substitutes
  • Bone Conductive Hearing Device
  • Brachytherapy
  • Breast reconstruction
  • Bronchial thermoplasty
  • Capsule endoscopy
  • Cardiac pacemakers
  • Cardiac resynchronization therapy
  • Carotid endarterectomy
  • Caesarean section
  • Cholecystectomy
  • Cochlear implants for hearing loss
  • Combined report for minimally invasive and transcatheter mitral valve repair and replacement procedures for mitral regurgitation
  • Computed tomography in ambulatory settings
  • Coronary artery bypass grafting
  • Coronary imaging and diagnostic procedures
  • Coronary percutaneous revascularization procedures
  • Deep brain stimulation
  • Diagnostic endoscopic procedures on the lower gastrointestinal tract
  • Diagnostic endoscopic procedures on the upper gastrointestinal tract
  • Endoscopic biliary procedures
  • Gastric electrical stimulation for gastroparesis and obesity
  • Health apps
  • Hemodialysis for acute kidney injury
  • Hemodialysis (out-patient session) for chronic kidney failure
  • Hernia repair
  • Hip replacement
  • Hospital and out-patient remote monitoring coding and reimbursement for neurostimulators
  • Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnea Syndrome (OSAS)
  • Hysterectomy
  • Embolic Protection Devices during percutaneous cardiac procedures (PCI and TAVI)
  • Endovascular repair (EVAR) of abdominal aortic aneurysm (AAA)
  • Extra-corporeal membrane oxygenation (ECMO) for pulmonary and cardiac failure
  • Image-guided radiotherapy
  • Implantable Cardiac Monitor for Detection of Cardiac Arrhythmia
  • Implantable cardioverter defibrillators (ICDs)
  • Implantable drug infusion systems for chronic pain
  • Inferior Vena Cava Filter
  • Intensity modulated radiotherapy (IMRT)
  • Left atrial appendage occlusion
  • Lung volume reduction for emphysema
  • Magnetic resonance imaging in ambulatory settings
  • Mechanical ventilzation
  • Mechanical thrombectomy for acute ischemic stroke
  • Minimally-invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
  • Minimally-invasive mitral valve repair with creation of artificial chordae tendonae for mitral regurgitation
  • Minimally-invasive replacement of mitral valve for mitral regurgitation
  • Minimally-invasive reshaping of heart geometry for mitral regurgitation
  • Negative Pressure Wound Therapy (NPWT) 
  • Open replacement of heart valves (all valves)
  • Percutaneous ablation procedures for diseases of lung, prostate, kidney, liver and bone
  • Percutaneous procedures for deep vein thrombosis
  • Percutaneous tibial neuromodulation in overactive bladder
  • Percutaneous vertebroplasty
  • Peripheral embolization procedure
  • Peripheral intravascular ultrasound
  • Peritoneal dialysis for chronic kidney failure
  • Proton Therapy
  • Robotic surgery interventions
  • Sacral nerve stimulation
  • Selective internal radiation therapy (SIRT)
  • Spinal cord stimulation
  • Stereotactic body radiation therapy
  • Stereotactic Radiosurgery
  • Surgical and endovascular treatment of brain aneurysm
  • Transcatheter annuloplasty ring for mitral regurgitation
  • Transcatheter aortic valve implantation (TAVI)
  • Transcatheter mitral annuloplasty using implant placed in the coronary sinus for mitral regurgitation
  • Transcatheter mitral valve leaflet repair using mitral clips for mitral regurgitation
  • Transcatheter mitral valve repair using mitral annulus plication for mitral regurgitation
  • Transcatheter mitral valve replacement
  • Treatment of varicose veins
  • Use of intra-aortic balloon pump (myocardial infarction and unstable angina, complicated by cardiogenic shock)
  • Vagus nerve stimulation
  • Vascular access for long-term use: AV fistula and AV graft
  • Ventricular assist devices for circulatory support
  • Volumetric modulated arc therapy (VMAT)

Ongoing reports:

  • Companion diagnostic tests for breast cancer
  • Treatment of burns
  • Biologic and synthetic skin substitutes